Stocklytics Platform
Asset logo for symbol VCEL
Vericel
VCEL75
$59.07arrow_drop_up4.79%$2.69
High Growth
Asset logo for symbol VCEL
VCEL75

$59.07

arrow_drop_up4.79%
Key Stats
Open$56.79
Prev. Close$56.35
EPS0.08
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range55.47
60.45
52 Week Range30.18
63.98
Ratios
EPS0.08
Fundamentals
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

VCEL-
US Healthcare Sector-
US Market-
check_circle

VCEL / Market

VCEL exceeded the US Market which returned 1.31% over the last twenty four hours.
check_circle

VCEL / Healthcare Sector

VCEL exceeded the US Healthcare sector which returned 2.66% over the last twenty four hours.

Vericel (VCEL) Statistics

Vericel Corp (VCEL) is a biopharmaceutical company that focuses on developing and commercializing innovative cellular therapies for the treatment of diseases. The company's main product is MACI, a cell-based therapy that is used for the repair and regeneration of cartilage defects in the knee. MACI has been approved by the FDA and has shown promising results in clinical trials. Vericel Corp is also developing other cellular therapies for the treatment of different diseases, including cardiac and skin disorders.
When it comes to valuation metrics, Vericel Corp has a market capitalization of around $2.5 billion. The company's price-to-earnings ratio is around 27, which indicates that investors are willing to pay a premium for the company's earnings. In terms of fundamentals, Vericel Corp has a strong balance sheet with total assets of around $650 million. The company has a healthy revenue growth rate, with revenue per share increasing steadily over the past few years.
add Vericel to watchlist

Keep an eye on Vericel

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Vericel (VCEL) stock's performance compared to its sector and the market over the past year?

Over the past year, Vericel (VCEL) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.66%, Vericel has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.84%, it has fallen short of the market average. This comparison highlights Vericel's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Vericel (VCEL) stock?

The PE (Price to Earnings) ratio of Vericel (VCEL) is currently 738.38. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Vericel (VCEL) stock?

The Earnings Per Share (EPS) for Vericel (VCEL), calculated on a diluted basis, is $0.08. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Vericel (VCEL) stock?

The operating margin for Vericel (VCEL) is -4.26%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Vericel (VCEL) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Vericel (VCEL) is $2.86M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Vericel (VCEL) have?

Vericel (VCEL) has a total debt of $97.46M. The net debt, which accounts for cash and cash equivalents against the total debt, is $43.78M.

Take Your Investments to a Whole New Level